Latest News about BMRN
Recent news which mentions BMRN
From Benzinga
From InvestorPlace
BioMarin Presents ~20% Upside Amid Voxzogo's Success and Slow Roctavian Uptake, Analyst Says
July 05, 2023
From Benzinga
From Benzinga
BioMarin's Roctavian US Launch: Focus on Commercial Strategy Amid EU Failures, Analyst Points Out
June 30, 2023
Tickers
BMRN
From Benzinga
From Benzinga
From Benzinga
3 Biotech Stocks to Buy With Explosive Upside Potential
June 22, 2023
From InvestorPlace
From InvestorPlace
From MarketWatch
From Benzinga
From Benzinga
3 Biotech Stocks With Blockbuster Potential
May 24, 2023
From InvestorPlace
A volatile summer is coming as Fed pause, debt tussle meet. Shelter in these stocks, says strategist
May 01, 2023
From MarketWatch
10 Health Care Stocks With Whale Alerts In Today's Session
April 20, 2023
From Benzinga
7 Biotech Stocks That Could Cure Your Portfolio Woes
April 19, 2023
From InvestorPlace
From Motley Fool
From Benzinga
After FDA Delays Hemophilia Gene Therapy, BioMarin's Dwarfism Drug Under FDA Review For Expanded Use
March 08, 2023
From Benzinga
Why BioMarin Shares Are Plunging Today?
March 06, 2023
From Benzinga
BioMarin Hints Probable Delay For US Approval For Roctavian, But Analyst Convinced For Transformative 2023
February 28, 2023
Tickers
BMRN
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.